INTRODUCTION
PTE is a life threatening condition with a mortality of 25%-30%; nevertheless, the mortality can be decreased to 2%-8% if the disease is properly diagnosed (1) . The main symptoms of this disease include respiratory distress, chest pain, lower arterial blood oxygen saturation, tachypnea and tachycardia (2) . Although pulmonary artery angiography constitutes a gold standard for diagnosing PTE, other para-clinical techniques such as simple chest x-rays, electrocardiogram, arterial blood gas (ABG) test, color Doppler ultrasonography, ventilation/perfusion scan, CT pulmonary angiography (CTPA) and D-dimer test can be used (3) . Research suggests that platelet activation plays a key role in patients with thrombotic problems, and the platelet activation process in PTE has been reported. An increase in MPV is a predictor factor for venous thromboembolism (VTE) with an unknown origin (4). Alidaei N. et al. found MPV to increase in PTE, and proposed a simple test to use in PTE patients (5). Song JE. et al. found high levels of platelets during chemotherapy to be a risk factor for PTE in cancer patients (6) . Given that platelets play a key role in developing thrombosis, variations in platelet indices appear to be effective in forming or intensifying the coagulation process and thromboembolism in patients with PTE, and platelet indices can be used to diagnose PTE (5) . Given the possibility of platelet activation in the incidence of VTE, the present study was conducted to evaluate the diagnostic value of platelet indices in patients with PTE.
METHODS

Study design and participants
The present case-control study was conducted from confidence interval of 0.95, while primary MPV data were obtained from the study of Alidaei N. (PTE group: 10.57±1.08 fl and control group: 9.80±0.86 fl) (5). The inclusion criterion comprised an acute dyspnea score of over 3 based on the Wells' criteria. The exclusion criteria consisted of having a history of blood diseases, i.e. myeloproliferative disorder and idiopathic thrombocytopenic purpura (ITP), hypothyroidism, pulmonary embolism and DVT, kidney failure, obesity (BMI>30) and rheumatic diseases, i.e. ankylosing spondylitis and rheumatoid arthritis. Convenience sampling was used to select the subjects. The present study was approved by the Ethics Committee of Tabriz University of Medical Sciences.
Data Gathering
After performing the primary evaluation of the eligible patients, blood samples were collected, and platelet indices were examined using an automated hematology analyzer (made in Japan). The patients were then admitted and evaluated for PTE. All the patients also underwent CT angiography (Siemens, Germany, 64 slices) of pulmonary arteries, and the reports were provided by a faculty member of Tabriz University of Medical Sciences as the radiologist. The patients were then divided into a case group comprising 125 patients with PTE and a control group comprising 48 patients without PTE.
Statistical analysis
The data collected were analyzed in SPSS-16. Furthermore, descriptive tests were used to describe the data. The Kolmogorov-Smirnov test was also used to investigate the distribution normality of the data, and the independent t-test to compare the quantitative data, and the Chi-squared test to compare the qualitative data. P<0.05 was set as the level of statistical significance.
RESULTS
Out of 173 patients with dyspnea and suspected of PTE, 125 were diagnosed with PTE. No significant relationships were observed between the two groups in terms of gender, age and BMI (Table 1) . Table 2 compares platelet indices between the two groups. Given the lack of any statistically significant differences between the two groups in term of platelet indices, the receiver operator curve (ROC) was not applicable to determining the sensitivity, specificity and cut off point of MPV, PDW and PL-CR for the diagnosis of PTE.
DISCUSSION
As a serious disease in emergency wards, PTE constitutes the cause of 100,000 deaths in the US (7, 8) . Given its high mortality and potential complications, the prompt diagnosis and treatment of this disease is crucial (9) . Research suggests an increase in MPV and PDW levels in PTE and the need for the use of MPV for diagnosing PTE (9) . In addition, MPV and PDW can be used to determine the intensity of pulmonary embolism (10) . Studies have shown that thrombocytosis is tightly related to the increased risk of acute symptomatic PTE, and helps with the prediction of its mortality and severity (11) . According to Icli A. et al., MPV increases in patients with deep vein thrombosis (DVT), and high levels of MPV can predict the risk of PTE in these patients (12) . Yardan T. et al. showed that MPV and MPV/platelet ratio are associated with the intensity of the clinical symptoms of PTE, and that lower rates of MPV and MPV/platelet ratio are related to lower risks of PTE (13). Huang J. et. al. found that MPV and PDW levels are significantly higher in patients with PTE, and that using MPV combined with D-Dimer helps diagnose PTE (9) . In contrast to the references cited, the present research did not suggest statistically significant differences between the patients with PTE and those without this condition in term of platelet indices, and did not observe any increases in PDW, 
